Metsera (MTSR) News Today $25.48 -0.30 (-1.16%) As of 10:09 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Metsera (NASDAQ:MTSR) Reaches New 52-Week Low - Here's What HappenedMetsera (NASDAQ:MTSR) Reaches New 52-Week Low - Here's What HappenedMarch 12 at 4:46 PM | marketbeat.comMetsera, Inc. Approves 2024 Executive Cash BonusesMarch 10 at 5:04 PM | tipranks.comMetsera (NASDAQ:MTSR) Shares Down 6.1% - What's Next?Metsera (NASDAQ:MTSR) Shares Down 6.1% - What's Next?March 8, 2025 | marketbeat.comMetsera, Inc.'s (NASDAQ:MTSR) Quiet Period Will End on March 12thMarch 7, 2025 | americanbankingnews.comMetsera, Inc.'s Quiet Period Will Expire on March 12th (NASDAQ:MTSR)Metsera's (NASDAQ:MTSR - Get Free Report) quiet period is set to expire on Wednesday, March 12th. Metsera had issued 15,277,778 shares in its public offering on January 31st. The total size of the offering was $275,000,004 based on an initial share price of $18.00. During Metsera's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.March 7, 2025 | marketbeat.comIs Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently?March 6, 2025 | msn.comMetsera, Inc.'s Quiet Period To Expire on March 12th (NASDAQ:MTSR)Metsera's (NASDAQ:MTSR - Get Free Report) quiet period will expire on Wednesday, March 12th. Metsera had issued 15,277,778 shares in its IPO on January 31st. The total size of the offering was $275,000,004 based on an initial share price of $18.00. During the company's quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.March 5, 2025 | marketbeat.comMetsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending RecentlyMarch 3, 2025 | msn.comMetsera (NASDAQ:MTSR) Trading Up 11.6% - What's Next?Metsera (NASDAQ:MTSR) Trading Up 11.6% - Time to Buy?March 3, 2025 | marketbeat.comMetsera, Inc.March 2, 2025 | cnn.comMetsera (NASDAQ:MTSR) Hits New 1-Year Low - What's Next?Metsera (NASDAQ:MTSR) Reaches New 1-Year Low - Time to Sell?February 28, 2025 | marketbeat.comCantor Fitzgerald Comments on Metsera FY2025 EarningsMetsera, Inc. (NASDAQ:MTSR - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Metsera in a note issued to investors on Tuesday, February 25th. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will earn ($3.38) per share for the year. Cantor FFebruary 28, 2025 | marketbeat.comWall Street bullish on Metsera following January IPO on obesity drug pipelineFebruary 26, 2025 | za.investing.comMetsera to Present at TD Cowen’s 45th Annual Health Care ConferenceFebruary 26, 2025 | markets.businessinsider.comMetsera started by Guggenheim at buy on obesity drug opportunityFebruary 26, 2025 | msn.comMetsera to Present at TD Cowen's 45th Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comMetsera started at buy at Guggenheim on obesity treatment potentialFebruary 25, 2025 | msn.comMetsera initiated with a Buy at BofAFebruary 25, 2025 | markets.businessinsider.comMetsera initiated with an Outperform at Evercore ISIFebruary 25, 2025 | markets.businessinsider.comThis weight-loss drug stock could deliver a 90% return in 2025February 25, 2025 | msn.comCantor Fitzgerald Begins Coverage on Metsera (NASDAQ:MTSR)Cantor Fitzgerald assumed coverage on Metsera in a report on Tuesday. They set an "overweight" rating on the stock.February 25, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Earns Buy Rating from Analysts at GuggenheimGuggenheim assumed coverage on Metsera in a research report on Tuesday. They issued a "buy" rating and a $56.00 target price on the stock.February 25, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Coverage Initiated by Analysts at Bank of AmericaBank of America initiated coverage on Metsera in a research note on Tuesday. They issued a "buy" rating and a $38.00 target price on the stock.February 25, 2025 | marketbeat.comMetsera, Inc.: A Promising Buy in the Obesity Market with Potential for Significant ReturnsFebruary 25, 2025 | tipranks.comMetsera initiated as Early-Stage Biotech at Goldman SachsFebruary 25, 2025 | markets.businessinsider.comMetsera (NASDAQ:MTSR) Sets New 12-Month High - Should You Buy?Metsera (NASDAQ:MTSR) Sets New 52-Week High - Should You Buy?February 19, 2025 | marketbeat.comMetsera (MTSR): Among Stocks Insiders Spent The Most Money On RecentlyFebruary 19, 2025 | msn.comInsider Buying Surges in February, Especially in These 6 StocksFebruary 9, 2025 | 247wallst.comMetsera Readies $275 Million IPO For Obesity TreatmentsJanuary 28, 2025 | seekingalpha.com Remove Ads Get Metsera News Delivered to You Automatically Sign up to receive the latest news and ratings for MTSR and its competitors with MarketBeat's FREE daily newsletter. Email Address MTSR Media Mentions By Week MTSR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MTSR News Sentiment▼0.590.71▲Average Medical News Sentiment MTSR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MTSR Articles This Week▼75▲MTSR Articles Average Week Remove Ads Get Metsera News Delivered to You Automatically Sign up to receive the latest news and ratings for MTSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SRPT News PCVX News ASND News QGEN News ROIV News RVMD News LNTH News LEGN News TLX News BBIO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MTSR) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metsera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metsera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
